Anti-ERN2/ IRE1-BETA/ IRE1b functional antibody

Anti-ERN2/ IRE1-BETA/ IRE1b functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to ERN2/ERN2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0184-Ab-1/ GM-Tg-hg-SE0184-Ab-2Anti-Human ERN2 monoclonal antibodyHuman
GM-Tg-rg-SE0184-Ab-1/ GM-Tg-rg-SE0184-Ab-2Anti-Rat ERN2 monoclonal antibodyRat
GM-Tg-mg-SE0184-Ab-1/ GM-Tg-mg-SE0184-Ab-2Anti-Mouse ERN2 monoclonal antibodyMouse
GM-Tg-cynog-SE0184-Ab-1/ GM-Tg-cynog-SE0184-Ab-2Anti-Cynomolgus/ Rhesus macaque ERN2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0184-Ab-1/ GM-Tg-felg-SE0184-Ab-2Anti-Feline ERN2 monoclonal antibodyFeline
GM-Tg-cang-SE0184-Ab-1/ GM-Tg-cang-SE0184-Ab-2Anti-Canine ERN2 monoclonal antibodyCanine
GM-Tg-bovg-SE0184-Ab-1/ GM-Tg-bovg-SE0184-Ab-2Anti-Bovine ERN2 monoclonal antibodyBovine
GM-Tg-equg-SE0184-Ab-1/ GM-Tg-equg-SE0184-Ab-2Anti-Equine ERN2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0184-Ab-1/ GM-Tg-hg-SE0184-Ab-2; GM-Tg-rg-SE0184-Ab-1/ GM-Tg-rg-SE0184-Ab-2;
GM-Tg-mg-SE0184-Ab-1/ GM-Tg-mg-SE0184-Ab-2; GM-Tg-cynog-SE0184-Ab-1/ GM-Tg-cynog-SE0184-Ab-2;
GM-Tg-felg-SE0184-Ab-1/ GM-Tg-felg-SE0184-Ab-2; GM-Tg-cang-SE0184-Ab-1/ GM-Tg-cang-SE0184-Ab-2;
GM-Tg-bovg-SE0184-Ab-1/ GM-Tg-bovg-SE0184-Ab-2; GM-Tg-equg-SE0184-Ab-1/ GM-Tg-equg-SE0184-Ab-2
Products NameAnti-ERN2 monoclonal antibody
Formatmab
Target NameERN2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ERN2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0184-Ag-1Recombinant multi-species ERN2/ IRE1-BETA/ IRE1b protein


    Target information

    Target IDGM-SE0184
    Target NameERN2
    Gene ID10595,26918,365363,700910,489970,101089482,508486,100069133
    Gene Symbol and SynonymsErn1,ERN2,hIRE2p,Ire1,IRE1-BETA,IRE1b,IRE2p,mIre1
    Uniprot AccessionQ76MJ5
    Uniprot Entry NameERN2_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000134398
    Target ClassificationKinase

    The target: ERN2, gene name: ERN2, also named as IRE1-BETA, IRE1b, IRE2p, hIRE2p. Enables several functions, including ATP binding activity; magnesium ion binding activity; and protein serine/threonine kinase activity. Involved in several processes, including apoptotic chromosome condensation; negative regulation of transcription, DNA-templated; and rRNA catabolic process. Predicted to be located in endoplasmic reticulum membrane and endoplasmic reticulum quality control compartment. Predicted to be integral component of membrane. Predicted to be part of IRE1-TRAF2-ASK1 complex. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.